• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Urinary Incontinence and Overactive Bladder: Sanctura Now FDA-Approved

Article

Trospium chloride (Sanctura) recentlybecame available for the treatmentof overactive bladder and urge urinaryincontinence. This drug, fromIndevus Pharmaceuticals, is a muscarinicreceptor antagonist that relaxesthe smooth muscle tissue of thebladder, thereby decreasing contractionsand counteracting overactive orunstable detrusor muscle function.

New Medication for
Urinary Incontinence/
Overactive BladderTrospium chloride (Sanctura) recentlybecame available for the treatmentof overactive bladder and urge urinaryincontinence. This drug, fromIndevus Pharmaceuticals, is a muscarinicreceptor antagonist that relaxesthe smooth muscle tissue of thebladder, thereby decreasing contractionsand counteracting overactive orunstable detrusor muscle function.The recommended dosage isone 20-mg tablet bid. The drug iscontraindicated in patients with urinaryor gastric retention or uncontrollednarrow-angle glaucoma--andin patients at risk for these conditions.The most common side effectsare dry mouth, constipation, andheadache.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
FDA Approves First New Antibiotic in Decades for Uncomplicated UTI in Women / image credit fda approval ©Walenmarus/stock.adobe.com

FDA Approves First New Antibiotic in Decades for Uncomplicated UTI

April 25th 2024
Article

Pivmecillinam is an aminopenicillin, a class of beta-lactam antibiotics with a mechanism of action that may help reduce rising levels of antibiotic resistance.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Poor Cardiovascular Health at Midlife Linked to Cognitive Decline in Black Women / Image credit: ©harunyigit/AdobeStock

Poor Cardiovascular Health at Midlife Linked to Cognitive Decline in Black Women

April 24th 2024
Article

Poor cardiovascular health at midlife was associated with a decline in the mental processing speed of Black women, but not White women, according to a new study.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

New Data Suggest Atrial Fibrillation May be More Common in Younger Adults than Previously Thought / Image credit: ©Horacio Selva/AdobeStock

New Data Suggest Atrial Fibrillation May be More Common in Younger Adults than Previously Thought

April 23rd 2024
Article

Patients with AF aged younger than 65 years have substantial comorbidity burden that may impact their future risk of mortality, reported researchers.

Breathlessness Related to Medical Conditions in Middle-Aged Adults: Daily Dose / image credit: ©New Africa/AdobeStock

Breathlessness Related to Medical Conditions in Middle-Aged Adults: Daily Dose

April 23rd 2024
Article

Your daily dose of the clinical news you may have missed.

© 2024 MJH Life Sciences

All rights reserved.